PDS Biotechnology CorporationPDSBNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +19.07% | +15.11% | +16.39% | +25.10% | +27.34% |
| Weighted Average Shares Diluted Growth | +19.07% | +15.11% | +16.39% | +25.10% | +27.34% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -8.28% | -23.63% | -31.85% | -33.09% | -33.83% |
| Book Value per Share Growth | -24.54% | -36.82% | -48.33% | -58.74% | -66.26% |
| Debt Growth | +4.51% | -8.49% | -21.35% | -23.96% | -27.17% |
| R&D Expense Growth | +5.51% | -39.33% | -13.02% | -6.95% | -32.74% |
| SG&A Expenses Growth | -17.10% | -4.27% | -3.50% | -17.95% | +5.60% |